38 results on '"Abraham, William T."'
Search Results
2. Heart Failure Drug Development Over the Eras: From the Heart Failure Collaboratory
3. Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory
4. Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse Populations
5. Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
6. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper
7. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial
8. Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
9. Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF
10. Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF
11. Remote Speech Analysis in the Evaluation of Hospitalized Patients With Acute Decompensated Heart Failure
12. Pulmonary Artery Pressure Monitoring Effectively Guides Management to Reduce Heart Failure Hospitalizations in Obesity
13. Prognostic Importance of Health Status Versus Functional Status in Heart Failure and Secondary Mitral Regurgitation
14. Sex-Specific Outcomes of Transcatheter Mitral-Valve Repair and Medical Therapy for Mitral Regurgitation in Heart Failure
15. Impact of Diabetes on Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: COAPT Trial
16. Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory
17. Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
18. Endpoints in Heart Failure Drug Development: History and Future
19. Novel Devices in Heart Failure: BAT, Atrial Shunts, and Phrenic Nerve Stimulation
20. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies
21. Design of a “Lean” Case Report Form for Heart Failure Therapeutic Development
22. Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial
23. Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis
24. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
25. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey
26. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial
27. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up
28. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring
29. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study
30. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction
31. Heart Failure Collaboratory Statement on Remote Monitoring and Social Distancing in the Landscape of COVID-19
32. Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19
33. Too Different or Too Late?
34. Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea
35. Reply
36. Ambulatory Extra-Aortic Counterpulsation in Patients With Moderate to Severe Chronic Heart Failure
37. Prevention of Atrial Fibrillation by Bucindolol Is Dependent on the Beta 1 389 Arg/Gly Adrenergic Receptor Polymorphism
38. Prevention of Atrial Fibrillation by Bucindolol Is Dependent on the Beta1389 Arg/Gly Adrenergic Receptor Polymorphism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.